Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2 as part of a small site update.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page. This represents an internal software version update for the platform rather than changes to visible content.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now indicates that no longer looking for participants, signaling that enrollment has ended. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment heading was standardized, and the page revision was bumped to v3.6.0.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page template. No study-specific content or functionality changes are indicated.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page's revision tag has been updated to Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page in the site's revision history.SummaryDifference0.0%

- Check72 days agoChange DetectedUpdated the location entry from Malmo, Sweden, 20502 to Malmö, Sweden, 20502 to reflect the correct spelling of the city name.SummaryDifference0.0%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.